Literature DB >> 22727990

Male sex, erythema nodosum, and electroretinography as predictors of visual prognosis after cataract surgery in patients with Behçet disease.

Ke Hu1, Bo Lei, Aize Kijlstra, Pinghua Li, Xuedong Zhang, Xiang Xiao, Fuzhen Li, Hong Xu, Peizeng Yang.   

Abstract

PURPOSE: To evaluate factors that predict the visual prognosis after cataract surgery in patients with Behçet disease.
SETTING: The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
DESIGN: Retrospective clinical study.
METHODS: Patients with Behçet disease and complicated cataract had phacoemulsification and intraocular lens implantation between September 2008 and March 2011. Analyzed were the corrected distance visual acuity (CDVA), full-field electroretinogram (ERG) results, intraocular inflammation, extraocular manifestations, and complications before and after surgery.
RESULTS: Twenty-one men (26 eyes) and 6 women (10 eyes) Behçet disease patients with complicated cataract were enrolled. There were no postoperative complications, although a mild to moderate anterior chamber reaction occurred in all patients. At the last visit, the CDVA was improved in 35 eyes. Twenty-seven eyes (75%) achieved a final CDVA of 0.1 or better. No female patient had obvious fundus complications, and all female patients achieved a final CDVA of 0.25 or better. The common causes for poor visual prognosis were optic atrophy, atrophy of the retina, and cystoid macular edema. Eyes with marked ERG a-wave and b-wave abnormalities had a significantly worse postoperative CDVA. Seven (10 eyes) of 8 patients (11 eyes) with a history of erythema nodosum had a postoperative visual acuity below 0.1.
CONCLUSIONS: Phacoemulsification and IOL implantation in patients with Behçet disease can be safely and successfully performed in quiet eyes. A poor visual prognosis was associated with male sex, severe fundus complications, and erythema nodosum and could be predicted by ERG abnormalities. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2012 ASCRS and ESCRS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727990     DOI: 10.1016/j.jcrs.2012.04.027

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

Review 1.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

Review 2.  Decision-making and management of uveitic cataract.

Authors:  Nicole Shu-Wen Chan; Seng-Ei Ti; Soon-Phaik Chee
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

3.  Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease.

Authors:  Abdullah Alfawaz; Sultan Alrashidi; Hatem Kalantan; Hani Al-Mezaine; Ahmed M Abu
Journal:  Ann Saudi Med       Date:  2014 Jul-Aug       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.